nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Docetaxel—head and neck cancer	0.342	0.416	CbGbCtD
Tenofovir—ABCC4—Fluorouracil—head and neck cancer	0.215	0.262	CbGbCtD
Tenofovir—ABCC2—Vinblastine—head and neck cancer	0.119	0.144	CbGbCtD
Tenofovir—ABCC2—Docetaxel—head and neck cancer	0.0979	0.119	CbGbCtD
Tenofovir—CYP1A2—Fluorouracil—head and neck cancer	0.0478	0.0581	CbGbCtD
Tenofovir—NME1—mouth—head and neck cancer	0.00442	0.0834	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—DPYD—head and neck cancer	0.00405	0.0593	CbGpPWpGaD
Tenofovir—NME1—neck—head and neck cancer	0.00378	0.0713	CbGeAlD
Tenofovir—AK4—saliva-secreting gland—head and neck cancer	0.00284	0.0536	CbGeAlD
Tenofovir—NME2—Nucleotide metabolism—DPYD—head and neck cancer	0.00281	0.0411	CbGpPWpGaD
Tenofovir—NME1-NME2—head—head and neck cancer	0.00274	0.0518	CbGeAlD
Tenofovir—Adenosine triphosphate—AKT1—head and neck cancer	0.00271	1	CrCbGaD
Tenofovir—NME1—connective tissue—head and neck cancer	0.00271	0.0511	CbGeAlD
Tenofovir—NME2—epithelium—head and neck cancer	0.00242	0.0457	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—XRCC3—head and neck cancer	0.00238	0.0349	CbGpPWpGaD
Tenofovir—AK2—thyroid gland—head and neck cancer	0.00234	0.0442	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—TYMS—head and neck cancer	0.00231	0.0338	CbGpPWpGaD
Tenofovir—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00224	0.0327	CbGpPWpGaD
Tenofovir—AK4—trachea—head and neck cancer	0.00219	0.0413	CbGeAlD
Tenofovir—AK2—Nucleotide metabolism—GPX1—head and neck cancer	0.00218	0.032	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—DPYD—head and neck cancer	0.00213	0.0311	CbGpPWpGaD
Tenofovir—NME1—lymphoid tissue—head and neck cancer	0.00198	0.0374	CbGeAlD
Tenofovir—NME1-NME2—lymph node—head and neck cancer	0.00192	0.0362	CbGeAlD
Tenofovir—NME1—Arf6 downstream pathway—MAPK3—head and neck cancer	0.00188	0.0275	CbGpPWpGaD
Tenofovir—NME2—lymphoid tissue—head and neck cancer	0.00186	0.0352	CbGeAlD
Tenofovir—NME1—thyroid gland—head and neck cancer	0.0018	0.0339	CbGeAlD
Tenofovir—Bone pain—Vinblastine—head and neck cancer	0.0018	0.0334	CcSEcCtD
Tenofovir—NME1—Arf6 downstream pathway—MAPK1—head and neck cancer	0.00179	0.0262	CbGpPWpGaD
Tenofovir—AK4—thyroid gland—head and neck cancer	0.00173	0.0327	CbGeAlD
Tenofovir—NME2—thyroid gland—head and neck cancer	0.00169	0.032	CbGeAlD
Tenofovir—Creatinine increased—Hydroxyurea—head and neck cancer	0.00165	0.0307	CcSEcCtD
Tenofovir—NME2—Nucleotide metabolism—TYMS—head and neck cancer	0.0016	0.0234	CbGpPWpGaD
Tenofovir—NME1—head—head and neck cancer	0.0016	0.0301	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—DPYD—head and neck cancer	0.00158	0.0232	CbGpPWpGaD
Tenofovir—AK4—head—head and neck cancer	0.00154	0.029	CbGeAlD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CDH1—head and neck cancer	0.00152	0.0222	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—GPX1—head and neck cancer	0.00151	0.0222	CbGpPWpGaD
Tenofovir—NME2—head—head and neck cancer	0.0015	0.0284	CbGeAlD
Tenofovir—AK2—lymph node—head and neck cancer	0.00146	0.0275	CbGeAlD
Tenofovir—ABCC10—parotid gland—head and neck cancer	0.00141	0.0265	CbGeAlD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00136	0.0199	CbGpPWpGaD
Tenofovir—ABCC10—saliva-secreting gland—head and neck cancer	0.00135	0.0254	CbGeAlD
Tenofovir—Renal failure acute—Hydroxyurea—head and neck cancer	0.00123	0.0229	CcSEcCtD
Tenofovir—NME1—Arf6 trafficking events—CDH1—head and neck cancer	0.00123	0.018	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—TYMS—head and neck cancer	0.00121	0.0177	CbGpPWpGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—head and neck cancer	0.00121	0.0177	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—GPX1—head and neck cancer	0.00115	0.0168	CbGpPWpGaD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—head and neck cancer	0.00113	0.0166	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—SMUG1—head and neck cancer	0.00113	0.0165	CbGpPWpGaD
Tenofovir—NME1—lymph node—head and neck cancer	0.00112	0.0211	CbGeAlD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.00108	0.0159	CbGpPWpGaD
Tenofovir—AK4—lymph node—head and neck cancer	0.00108	0.0203	CbGeAlD
Tenofovir—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00107	0.0198	CcSEcCtD
Tenofovir—NME2—lymph node—head and neck cancer	0.00105	0.0199	CbGeAlD
Tenofovir—ABCC10—trachea—head and neck cancer	0.00104	0.0196	CbGeAlD
Tenofovir—AK2—Metabolism—UROD—head and neck cancer	0.00101	0.0148	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000986	0.0144	CbGpPWpGaD
Tenofovir—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000976	0.0143	CbGpPWpGaD
Tenofovir—Pancreatitis—Hydroxyurea—head and neck cancer	0.000965	0.018	CcSEcCtD
Tenofovir—Depression—Vinblastine—head and neck cancer	0.00096	0.0179	CcSEcCtD
Tenofovir—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000944	0.0175	CcSEcCtD
Tenofovir—ABCC10—lymphoid tissue—head and neck cancer	0.000905	0.0171	CbGeAlD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TYMS—head and neck cancer	0.000903	0.0132	CbGpPWpGaD
Tenofovir—Infestation NOS—Hydroxyurea—head and neck cancer	0.000878	0.0163	CcSEcCtD
Tenofovir—Infestation—Hydroxyurea—head and neck cancer	0.000878	0.0163	CcSEcCtD
Tenofovir—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000861	0.016	CcSEcCtD
Tenofovir—Bone pain—Docetaxel—head and neck cancer	0.000851	0.0158	CcSEcCtD
Tenofovir—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.000832	0.0122	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00083	0.0154	CcSEcCtD
Tenofovir—ABCC10—thyroid gland—head and neck cancer	0.000822	0.0155	CbGeAlD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—PIK3CA—head and neck cancer	0.000771	0.0113	CbGpPWpGaD
Tenofovir—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000757	0.0111	CbGpPWpGaD
Tenofovir—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000733	0.0136	CcSEcCtD
Tenofovir—Muscular weakness—Fluorouracil—head and neck cancer	0.000723	0.0134	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—head and neck cancer	0.000706	0.0103	CbGpPWpGaD
Tenofovir—NME2—Metabolism—UROD—head and neck cancer	0.0007	0.0103	CbGpPWpGaD
Tenofovir—ABCC4—thyroid gland—head and neck cancer	0.000682	0.0129	CbGeAlD
Tenofovir—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000659	0.0122	CcSEcCtD
Tenofovir—Pneumonia—Fluorouracil—head and neck cancer	0.000636	0.0118	CcSEcCtD
Tenofovir—Infestation NOS—Fluorouracil—head and neck cancer	0.000632	0.0118	CcSEcCtD
Tenofovir—Infestation—Fluorouracil—head and neck cancer	0.000632	0.0118	CcSEcCtD
Tenofovir—NME1—E-cadherin signaling in the nascent adherens junction—AKT1—head and neck cancer	0.00063	0.00922	CbGpPWpGaD
Tenofovir—Renal impairment—Docetaxel—head and neck cancer	0.000622	0.0116	CcSEcCtD
Tenofovir—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000619	0.0115	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000612	0.00896	CbGpPWpGaD
Tenofovir—ABCC4—head—head and neck cancer	0.000605	0.0114	CbGeAlD
Tenofovir—SLC22A8—head—head and neck cancer	0.0006	0.0113	CbGeAlD
Tenofovir—Sinusitis—Fluorouracil—head and neck cancer	0.000593	0.011	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000592	0.00867	CbGpPWpGaD
Tenofovir—Anorexia—Vinblastine—head and neck cancer	0.000585	0.0109	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00058	0.0108	CcSEcCtD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—head and neck cancer	0.000567	0.0083	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000564	0.00826	CbGpPWpGaD
Tenofovir—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000549	0.0102	CcSEcCtD
Tenofovir—Skin disorder—Hydroxyurea—head and neck cancer	0.000544	0.0101	CcSEcCtD
Tenofovir—Anorexia—Hydroxyurea—head and neck cancer	0.000534	0.00993	CcSEcCtD
Tenofovir—Decreased appetite—Vinblastine—head and neck cancer	0.000534	0.00993	CcSEcCtD
Tenofovir—NME1—Metabolism—UROD—head and neck cancer	0.000531	0.00777	CbGpPWpGaD
Tenofovir—Nasopharyngitis—Docetaxel—head and neck cancer	0.000529	0.00984	CcSEcCtD
Tenofovir—Pain—Vinblastine—head and neck cancer	0.000525	0.00976	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000525	0.00769	CbGpPWpGaD
Tenofovir—ABCC10—lymph node—head and neck cancer	0.000511	0.00964	CbGeAlD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000511	0.00748	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000502	0.00934	CcSEcCtD
Tenofovir—Dyspnoea—Hydroxyurea—head and neck cancer	0.000499	0.00928	CcSEcCtD
Tenofovir—Dyspepsia—Hydroxyurea—head and neck cancer	0.000493	0.00917	CcSEcCtD
Tenofovir—Decreased appetite—Hydroxyurea—head and neck cancer	0.000487	0.00905	CcSEcCtD
Tenofovir—Abdominal pain—Vinblastine—head and neck cancer	0.000485	0.00903	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000483	0.00899	CcSEcCtD
Tenofovir—Fatigue—Hydroxyurea—head and neck cancer	0.000483	0.00898	CcSEcCtD
Tenofovir—Pain—Hydroxyurea—head and neck cancer	0.000479	0.0089	CcSEcCtD
Tenofovir—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000478	0.00699	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFA—head and neck cancer	0.000467	0.00684	CbGpPWpGaD
Tenofovir—CYP1A2—thyroid gland—head and neck cancer	0.000463	0.00874	CbGeAlD
Tenofovir—Weight decreased—Docetaxel—head and neck cancer	0.000463	0.00861	CcSEcCtD
Tenofovir—Pneumonia—Docetaxel—head and neck cancer	0.000459	0.00853	CcSEcCtD
Tenofovir—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000459	0.00671	CbGpPWpGaD
Tenofovir—Infestation NOS—Docetaxel—head and neck cancer	0.000456	0.00848	CcSEcCtD
Tenofovir—Infestation—Docetaxel—head and neck cancer	0.000456	0.00848	CcSEcCtD
Tenofovir—Hypersensitivity—Vinblastine—head and neck cancer	0.000452	0.00841	CcSEcCtD
Tenofovir—Renal failure—Docetaxel—head and neck cancer	0.000448	0.00834	CcSEcCtD
Tenofovir—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000447	0.00831	CcSEcCtD
Tenofovir—Body temperature increased—Hydroxyurea—head and neck cancer	0.000443	0.00823	CcSEcCtD
Tenofovir—Asthenia—Vinblastine—head and neck cancer	0.000441	0.00819	CcSEcCtD
Tenofovir—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000435	0.00637	CbGpPWpGaD
Tenofovir—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000431	0.00802	CcSEcCtD
Tenofovir—ABCC4—lymph node—head and neck cancer	0.000424	0.008	CbGeAlD
Tenofovir—Chest pain—Fluorouracil—head and neck cancer	0.00042	0.00782	CcSEcCtD
Tenofovir—Myalgia—Fluorouracil—head and neck cancer	0.00042	0.00782	CcSEcCtD
Tenofovir—Diarrhoea—Vinblastine—head and neck cancer	0.00042	0.00781	CcSEcCtD
Tenofovir—AK2—Metabolism—NAT2—head and neck cancer	0.000419	0.00614	CbGpPWpGaD
Tenofovir—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000413	0.00767	CcSEcCtD
Tenofovir—ABCC2—lymph node—head and neck cancer	0.00041	0.00774	CbGeAlD
Tenofovir—Hepatitis—Docetaxel—head and neck cancer	0.000409	0.00761	CcSEcCtD
Tenofovir—Dizziness—Vinblastine—head and neck cancer	0.000406	0.00755	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000405	0.00592	CbGpPWpGaD
Tenofovir—Urinary tract disorder—Docetaxel—head and neck cancer	0.000404	0.00752	CcSEcCtD
Tenofovir—Connective tissue disorder—Docetaxel—head and neck cancer	0.000402	0.00748	CcSEcCtD
Tenofovir—Asthenia—Hydroxyurea—head and neck cancer	0.000402	0.00747	CcSEcCtD
Tenofovir—Urethral disorder—Docetaxel—head and neck cancer	0.000401	0.00746	CcSEcCtD
Tenofovir—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.0004	0.00585	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—head and neck cancer	0.000398	0.00582	CbGpPWpGaD
Tenofovir—Nervous system disorder—Fluorouracil—head and neck cancer	0.000395	0.00735	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—TGFA—head and neck cancer	0.000394	0.00577	CbGpPWpGaD
Tenofovir—Vomiting—Vinblastine—head and neck cancer	0.00039	0.00726	CcSEcCtD
Tenofovir—Headache—Vinblastine—head and neck cancer	0.000385	0.00715	CcSEcCtD
Tenofovir—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000384	0.00563	CbGpPWpGaD
Tenofovir—Anorexia—Fluorouracil—head and neck cancer	0.000384	0.00714	CcSEcCtD
Tenofovir—Diarrhoea—Hydroxyurea—head and neck cancer	0.000383	0.00712	CcSEcCtD
Tenofovir—Dizziness—Hydroxyurea—head and neck cancer	0.00037	0.00689	CcSEcCtD
Tenofovir—Immune system disorder—Docetaxel—head and neck cancer	0.00037	0.00688	CcSEcCtD
Tenofovir—Mediastinal disorder—Docetaxel—head and neck cancer	0.000369	0.00686	CcSEcCtD
Tenofovir—AK2—Metabolism—DPYD—head and neck cancer	0.000368	0.00538	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000367	0.00683	CcSEcCtD
Tenofovir—Nausea—Vinblastine—head and neck cancer	0.000365	0.00678	CcSEcCtD
Tenofovir—Insomnia—Fluorouracil—head and neck cancer	0.000365	0.00678	CcSEcCtD
Tenofovir—Dyspnoea—Fluorouracil—head and neck cancer	0.000359	0.00668	CcSEcCtD
Tenofovir—Mental disorder—Docetaxel—head and neck cancer	0.000359	0.00667	CcSEcCtD
Tenofovir—Malnutrition—Docetaxel—head and neck cancer	0.000356	0.00663	CcSEcCtD
Tenofovir—Vomiting—Hydroxyurea—head and neck cancer	0.000356	0.00662	CcSEcCtD
Tenofovir—Dyspepsia—Fluorouracil—head and neck cancer	0.000355	0.0066	CcSEcCtD
Tenofovir—Rash—Hydroxyurea—head and neck cancer	0.000353	0.00657	CcSEcCtD
Tenofovir—Dermatitis—Hydroxyurea—head and neck cancer	0.000353	0.00656	CcSEcCtD
Tenofovir—Headache—Hydroxyurea—head and neck cancer	0.000351	0.00652	CcSEcCtD
Tenofovir—Decreased appetite—Fluorouracil—head and neck cancer	0.00035	0.00652	CcSEcCtD
Tenofovir—AK2—Metabolism—YAP1—head and neck cancer	0.000349	0.00511	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000348	0.00647	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000347	0.00508	CbGpPWpGaD
Tenofovir—Back pain—Docetaxel—head and neck cancer	0.000345	0.00641	CcSEcCtD
Tenofovir—Pain—Fluorouracil—head and neck cancer	0.000345	0.00641	CcSEcCtD
Tenofovir—Nausea—Hydroxyurea—head and neck cancer	0.000333	0.00618	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.00033	0.00483	CbGpPWpGaD
Tenofovir—Body temperature increased—Fluorouracil—head and neck cancer	0.000319	0.00592	CcSEcCtD
Tenofovir—Chest pain—Docetaxel—head and neck cancer	0.000303	0.00564	CcSEcCtD
Tenofovir—Myalgia—Docetaxel—head and neck cancer	0.000303	0.00564	CcSEcCtD
Tenofovir—Arthralgia—Docetaxel—head and neck cancer	0.000303	0.00564	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000301	0.0056	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—head and neck cancer	0.000299	0.00438	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000298	0.00436	CbGpPWpGaD
Tenofovir—Hypersensitivity—Fluorouracil—head and neck cancer	0.000297	0.00552	CcSEcCtD
Tenofovir—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000297	0.00435	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NAT2—head and neck cancer	0.000291	0.00426	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000288	0.00421	CbGpPWpGaD
Tenofovir—Nervous system disorder—Docetaxel—head and neck cancer	0.000285	0.0053	CcSEcCtD
Tenofovir—Pruritus—Fluorouracil—head and neck cancer	0.000285	0.0053	CcSEcCtD
Tenofovir—Skin disorder—Docetaxel—head and neck cancer	0.000283	0.00525	CcSEcCtD
Tenofovir—Anorexia—Docetaxel—head and neck cancer	0.000277	0.00516	CcSEcCtD
Tenofovir—Diarrhoea—Fluorouracil—head and neck cancer	0.000276	0.00513	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—GSTM1—head and neck cancer	0.000272	0.00398	CbGpPWpGaD
Tenofovir—Dizziness—Fluorouracil—head and neck cancer	0.000267	0.00496	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000265	0.00493	CcSEcCtD
Tenofovir—Insomnia—Docetaxel—head and neck cancer	0.000263	0.00489	CcSEcCtD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000262	0.00383	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000261	0.00382	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.00026	0.0038	CbGpPWpGaD
Tenofovir—Dyspnoea—Docetaxel—head and neck cancer	0.000259	0.00482	CcSEcCtD
Tenofovir—Vomiting—Fluorouracil—head and neck cancer	0.000256	0.00477	CcSEcCtD
Tenofovir—Dyspepsia—Docetaxel—head and neck cancer	0.000256	0.00476	CcSEcCtD
Tenofovir—NME2—Metabolism—DPYD—head and neck cancer	0.000255	0.00373	CbGpPWpGaD
Tenofovir—Rash—Fluorouracil—head and neck cancer	0.000254	0.00473	CcSEcCtD
Tenofovir—Dermatitis—Fluorouracil—head and neck cancer	0.000254	0.00472	CcSEcCtD
Tenofovir—Decreased appetite—Docetaxel—head and neck cancer	0.000253	0.0047	CcSEcCtD
Tenofovir—Headache—Fluorouracil—head and neck cancer	0.000253	0.0047	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000251	0.00467	CcSEcCtD
Tenofovir—Fatigue—Docetaxel—head and neck cancer	0.000251	0.00466	CcSEcCtD
Tenofovir—Pain—Docetaxel—head and neck cancer	0.000249	0.00463	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000246	0.0036	CbGpPWpGaD
Tenofovir—NME2—Metabolism—YAP1—head and neck cancer	0.000242	0.00354	CbGpPWpGaD
Tenofovir—Nausea—Fluorouracil—head and neck cancer	0.000239	0.00445	CcSEcCtD
Tenofovir—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000238	0.00442	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000234	0.00342	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000234	0.00342	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000232	0.0034	CbGpPWpGaD
Tenofovir—Abdominal pain—Docetaxel—head and neck cancer	0.00023	0.00428	CcSEcCtD
Tenofovir—Body temperature increased—Docetaxel—head and neck cancer	0.00023	0.00428	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—head and neck cancer	0.000229	0.00335	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000223	0.00326	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NAT2—head and neck cancer	0.00022	0.00323	CbGpPWpGaD
Tenofovir—Hypersensitivity—Docetaxel—head and neck cancer	0.000214	0.00399	CcSEcCtD
Tenofovir—AK2—Metabolism—TYMS—head and neck cancer	0.00021	0.00307	CbGpPWpGaD
Tenofovir—Asthenia—Docetaxel—head and neck cancer	0.000209	0.00388	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTM1—head and neck cancer	0.000207	0.00303	CbGpPWpGaD
Tenofovir—Pruritus—Docetaxel—head and neck cancer	0.000206	0.00383	CcSEcCtD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000205	0.00301	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000205	0.00301	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000205	0.00301	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000203	0.00297	CbGpPWpGaD
Tenofovir—Diarrhoea—Docetaxel—head and neck cancer	0.000199	0.0037	CcSEcCtD
Tenofovir—AK2—Metabolism—GPX1—head and neck cancer	0.000198	0.0029	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1A1—head and neck cancer	0.000196	0.00288	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000196	0.00287	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—head and neck cancer	0.000195	0.00286	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000194	0.00284	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000194	0.00284	CbGpPWpGaD
Tenofovir—NME1—Metabolism—DPYD—head and neck cancer	0.000193	0.00283	CbGpPWpGaD
Tenofovir—Dizziness—Docetaxel—head and neck cancer	0.000192	0.00358	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000192	0.00281	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000188	0.00275	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000186	0.00272	CbGpPWpGaD
Tenofovir—Vomiting—Docetaxel—head and neck cancer	0.000185	0.00344	CcSEcCtD
Tenofovir—Rash—Docetaxel—head and neck cancer	0.000183	0.00341	CcSEcCtD
Tenofovir—NME1—Metabolism—YAP1—head and neck cancer	0.000183	0.00268	CbGpPWpGaD
Tenofovir—Dermatitis—Docetaxel—head and neck cancer	0.000183	0.00341	CcSEcCtD
Tenofovir—Headache—Docetaxel—head and neck cancer	0.000182	0.00339	CcSEcCtD
Tenofovir—Nausea—Docetaxel—head and neck cancer	0.000173	0.00321	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000166	0.00243	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000166	0.00243	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000164	0.0024	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000153	0.00223	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000151	0.0022	CbGpPWpGaD
Tenofovir—NME2—Metabolism—TYMS—head and neck cancer	0.000145	0.00213	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTM1—head and neck cancer	0.000144	0.0021	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GPX1—head and neck cancer	0.000138	0.00201	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1A1—head and neck cancer	0.000136	0.00199	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000135	0.00197	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000129	0.00189	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000122	0.00179	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—head and neck cancer	0.000117	0.00171	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000114	0.00167	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000113	0.00166	CbGpPWpGaD
Tenofovir—NME1—Metabolism—TYMS—head and neck cancer	0.00011	0.00161	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—head and neck cancer	0.000109	0.00159	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GPX1—head and neck cancer	0.000104	0.00153	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—head and neck cancer	0.000103	0.00151	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—head and neck cancer	0.000102	0.00149	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.000102	0.00149	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	9.62e-05	0.00141	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	8.65e-05	0.00127	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	8.65e-05	0.00127	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	8.65e-05	0.00127	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	8.65e-05	0.00127	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	8.19e-05	0.0012	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—head and neck cancer	8.1e-05	0.00119	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	7.79e-05	0.00114	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	7.54e-05	0.0011	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	7.44e-05	0.00109	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—head and neck cancer	7.19e-05	0.00105	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	7.15e-05	0.00105	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—head and neck cancer	7.06e-05	0.00103	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	7.05e-05	0.00103	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	6.95e-05	0.00102	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	6.76e-05	0.00099	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—UROD—head and neck cancer	6.29e-05	0.00092	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—head and neck cancer	6.13e-05	0.000898	CbGpPWpGaD
Tenofovir—AK2—Metabolism—AKT1—head and neck cancer	5.87e-05	0.000859	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	5.52e-05	0.000808	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—head and neck cancer	5.35e-05	0.000783	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—head and neck cancer	5.25e-05	0.000769	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—head and neck cancer	4.98e-05	0.000729	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.88e-05	0.000714	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—head and neck cancer	4.46e-05	0.000653	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK3—head and neck cancer	4.22e-05	0.000618	CbGpPWpGaD
Tenofovir—NME2—Metabolism—AKT1—head and neck cancer	4.07e-05	0.000596	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK1—head and neck cancer	4.02e-05	0.000588	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—head and neck cancer	3.77e-05	0.000553	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—head and neck cancer	3.48e-05	0.00051	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—head and neck cancer	3.37e-05	0.000494	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—HRAS—head and neck cancer	3.22e-05	0.000472	CbGpPWpGaD
Tenofovir—NME1—Metabolism—AKT1—head and neck cancer	3.08e-05	0.000451	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—AKT1—head and neck cancer	2.85e-05	0.000417	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.77e-05	0.000406	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.74e-05	0.000402	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NAT2—head and neck cancer	2.61e-05	0.000382	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—DPYD—head and neck cancer	2.29e-05	0.000335	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—YAP1—head and neck cancer	2.17e-05	0.000318	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.63e-05	0.000239	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.42e-05	0.000208	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TYMS—head and neck cancer	1.3e-05	0.000191	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.29e-05	0.000189	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPX1—head and neck cancer	1.23e-05	0.000181	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.22e-05	0.000179	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1e-05	0.000147	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—head and neck cancer	7.27e-06	0.000106	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—head and neck cancer	6.34e-06	9.28e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—head and neck cancer	4.47e-06	6.55e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—AKT1—head and neck cancer	3.65e-06	5.35e-05	CbGpPWpGaD
